Lau N - Search Results

1

Expression and activation of epidermal growth factor receptors in meningiomas.

Carroll RS, Black PM, Zhang J, Kirsch M, Percec I, Lau N, Guha A. Carroll RS, et al. Among authors: lau n. J Neurosurg. 1997 Aug;87(2):315-23. doi: 10.3171/jns.1997.87.2.0315. J Neurosurg. 1997. PMID: 9254099

2

Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema.

Provias J, Claffey K, delAguila L, Lau N, Feldkamp M, Guha A. Provias J, et al. Among authors: lau n. Neurosurgery. 1997 May;40(5):1016-26. doi: 10.1097/00006123-199705000-00027. Neurosurgery. 1997. PMID: 9149260

3

Aberrant G protein signaling in nervous system tumors.

Woods SA, Marmor E, Feldkamp M, Lau N, Apicelli AJ, Boss G, Gutmann DH, Guha A. Woods SA, et al. Among authors: lau n. J Neurosurg. 2002 Sep;97(3):627-42. doi: 10.3171/jns.2002.97.3.0627. J Neurosurg. 2002. PMID: 12296648 Review.

4

Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens.

Feldkamp MM, Lala P, Lau N, Roncari L, Guha A. Feldkamp MM, et al. Among authors: lau n. Neurosurgery. 1999 Dec;45(6):1442-53. doi: 10.1097/00006123-199912000-00034. Neurosurgery. 1999. PMID: 10598712

5

Acute presentation of a neurogenic sarcoma in a patient with neurofibromatosis type 1: a pathological and molecular explanation. Case report.

Feldkamp MM, Lau N, Provias JP, Gutmann DH, Guha A. Feldkamp MM, et al. Among authors: lau n. J Neurosurg. 1996 May;84(5):867-73. doi: 10.3171/jns.1996.84.5.0867. J Neurosurg. 1996. PMID: 8622163

6

Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects.

Feldkamp MM, Lau N, Guha A. Feldkamp MM, et al. Among authors: lau n. Oncogene. 1999 Dec 9;18(52):7514-26. doi: 10.1038/sj.onc.1203105. Oncogene. 1999. PMID: 10602510

7

Isotype-specific Ras.GTP-levels predict the efficacy of farnesyl transferase inhibitors against human astrocytomas regardless of Ras mutational status.

Feldkamp MM, Lau N, Roncari L, Guha A. Feldkamp MM, et al. Among authors: lau n. Cancer Res. 2001 Jun 1;61(11):4425-31. Cancer Res. 2001. PMID: 11389071

8

Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras.

Feldkamp MM, Lau N, Rak J, Kerbel RS, Guha A. Feldkamp MM, et al. Among authors: lau n. Int J Cancer. 1999 Mar 31;81(1):118-24. doi: 10.1002/(sici)1097-0215(19990331)81:1<118::aid-ijc20>3.0.co;2-5. Int J Cancer. 1999. PMID: 10077162

9

Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma.

Lau N, Feldkamp MM, Roncari L, Loehr AH, Shannon P, Gutmann DH, Guha A. Lau N, et al. J Neuropathol Exp Neurol. 2000 Sep;59(9):759-67. doi: 10.1093/jnen/59.9.759. J Neuropathol Exp Neurol. 2000. PMID: 11005256

10

Proliferation of human malignant astrocytomas is dependent on Ras activation.

Guha A, Feldkamp MM, Lau N, Boss G, Pawson A. Guha A, et al. Among authors: lau n. Oncogene. 1997 Dec 4;15(23):2755-65. doi: 10.1038/sj.onc.1201455. Oncogene. 1997. PMID: 9419966

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

430 results

Search Page

Filters